The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the
Pennant group of affiliated home health, hospice and senior living
companies, today announced its operating results for the third
quarter of 2024, reporting GAAP diluted earnings per share of $0.20
for the third quarter of 2024. Pennant also reported adjusted
diluted earnings per share of $0.26 for the quarter (1).
Third Quarter Highlights
- Total revenue for the third quarter
was $180.7 million, an increase of $40.5 million or 28.9% over the
prior year quarter;
- Net income for the third quarter was
$6.2 million, an increase of $1.8 million or 41.6% over the prior
year quarter;
- Adjusted net income for the third
quarter was $8.2 million, an increase of $2.2 million or 36.8% over
the prior year quarter;
- Segment Adjusted EBITDAR from
Operations for the third quarter was $26.0 million, an increase of
$5.4 million or 25.9% over the prior year quarter;
- Adjusted EBITDA for the third quarter
was $15.1 million, an increase of $4.3 million or 39.2% over the
prior year quarter;
- Home Health and Hospice Services
segment revenue for the third quarter was $135.7 million, an
increase of $34.2 million or 33.7% over the prior year
quarter;
- Home Health and Hospice Services
segment adjusted EBITDAR from operations for the third quarter was
$23.7 million, an increase of $6.5 million or 37.4% over the prior
year quarter; and segment adjusted EBITDA from operations the third
quarter was $21.9 million, an increase of $6.0 million or 37.5%
over the prior year quarter;
- Total home health admissions for the
third quarter were 14,993, an increase of 4,164 or 38.5% over the
prior year quarter; total Medicare home health admissions for the
third quarter were 6,071, an increase of 1,431 or 30.8% over the
prior year quarter;
- Hospice average daily census for the
third quarter was 3,444, an increase of 746 or 27.7% compared to
the prior year quarter;
- Senior Living Services segment revenue
for the third quarter was $45.0 million, an increase of $6.3
million or 16.3% over the prior year quarter; average occupancy for
the third quarter was 79.1%, an increase of 20 basis points over
the prior year quarter, and average monthly revenue per occupied
room for the third quarter was $4,836 an increase of $350 or 7.8%
over the prior year quarter;
- Senior Living segment adjusted EBITDAR
from operations for the third quarter was $13.4 million, an
increase of $1.9 million or 16.9% over the prior year quarter; and
segment adjusted EBITDA from Operations for the third quarter was
$4.4 million, an increase of $1.3 million or 43.8% over the prior
year quarter.
(1 |
) |
|
See "Reconciliation of GAAP to Non-GAAP Financial
Information.” |
|
|
|
|
Operating Results
“Our strong third quarter financial results
demonstrate the momentum we are building across the business, and
we are pleased to see robust performance in our existing operations
even as we integrate new ones. The equity offering we executed
after quarter end, coupled with the expansion of our revolving
credit facility during the quarter, position us exceptionally well
for future growth. With these operating results and a healthy
balance sheet, we are poised for success through the remainder of
2024 and beyond,” said Brent Guerisoli, the Company’s Chief
Executive Officer.
A discussion of the Company's use of Non-GAAP
financial measures is set forth below. A reconciliation of net
income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as
a reconciliation of GAAP earnings per share, net income to adjusted
net earnings per share and adjusted net income, appear in the
financial data portion of this release. More complete information
is contained in the Company’s Form 10-Q for the three and nine
months ended September 30, 2024, which has been filed with the SEC
today and can be viewed on the Company’s website at
www.pennantgroup.com.
2024 Guidance
Management is updating its annual guidance as
follows: total revenue is anticipated to be between $665.3 million
and $706.5 million; full year 2024 adjusted earnings per diluted
share is anticipated to be between $0.90 and $0.96; and full year
2024 adjusted EBITDA is anticipated to be between $51.9 million and
$55.2 million.
“The Company’s updated guidance reflects the
continued momentum in the business, and incorporates current
operations and organic growth, diluted weighted average shares
outstanding of approximately 32.5 million, and a 26.0% effective
tax rate,” stated Lynette Walbom, Pennant’s Chief Financial
Officer. “It anticipates consistent operating performance through
the end of the year, hospice reimbursement rate adjustments,
decreased interest expense, and contributions from our joint
ventures and management agreements. It excludes unannounced
acquisitions, the announced purchase of Signature’s Oregon assets,
start-ups, share-based compensation, acquisition-related costs, or
one-time implementation and unusual items.”
Conference Call
A live webcast will be held tomorrow,
November 7, 2024 at 10:00 a.m. Mountain time (12:00 p.m.
Eastern time) to discuss Pennant’s third quarter 2024 financial
results. To listen to the webcast, or to view any financial or
statistical information required by SEC Regulation G, please visit
the Investors Relations section of Pennant’s website at
https://investor.pennantgroup.com. The webcast will be recorded and
will be available for replay via the website.
About Pennant
The Pennant Group, Inc. is a holding company of
independent operating subsidiaries that provide healthcare services
through 122 home health and hospice agencies and 54 senior living
communities located throughout Arizona, California, Colorado,
Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington,
Wisconsin and Wyoming. Each of these businesses is operated by a
separate, independent operating subsidiary that has its own
management, employees and assets. References herein to the
consolidated "company" and "its" assets and activities, as well as
the use of the terms "we," "us," "its" and similar verbiage, are
not meant to imply that The Pennant Group, Inc. has direct
operating assets, employees or revenue, or that any of the home
health and hospice businesses, senior living communities or the
Service Center are operated by the same entity. More information
about Pennant is available at www.pennantgroup.com.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995
This press release contains, and the related
conference call and webcast will include, forward-looking
statements that are based on management’s current expectations,
assumptions and beliefs about its business, financial performance,
operating results, the industry in which it operates and other
future events. Forward-looking statements can often be identified
by words such as "anticipates," "expects," "intends," "plans,"
"predicts," "believes," "seeks," "estimates," "may," "will,"
"should," "would," "could," "potential," "continue," "ongoing,"
similar expressions, and variations or negatives of these words.
These forward-looking statements include, but are not limited to,
statements regarding growth prospects, future operating and
financial performance, and acquisition activities. They are not
guarantees of future results and are subject to risks,
uncertainties and assumptions that could cause actual results to
materially and adversely differ from those expressed in any
forward-looking statement.
These risks and uncertainties relate to the
company’s business, its industry and its common stock and include:
reduced prices and reimbursement rates for its services; its
ability to acquire, develop, manage or improve operations, its
ability to manage its increasing borrowing costs as it incurs
additional indebtedness to fund the acquisition and development of
operations; its ability to access capital on a cost-effective basis
to continue to successfully implement its growth strategy; its
operating margins and profitability could suffer if it is unable to
grow and manage effectively its increasing number of operations;
competition from other companies in the acquisition, development
and operation of facilities; its ability to defend claims and
lawsuits, including professional liability claims alleging that our
services resulted in personal injury, and other regulatory-related
claims; and the application of existing or proposed government
regulations, or the adoption of new laws and regulations, that
could limit its business operations, require it to incur
significant expenditures or limit its ability to relocate its
operations if necessary. Readers should not place undue reliance on
any forward-looking statements and are encouraged to review the
company’s periodic filings with the Securities and Exchange
Commission, including its Form 10-Q and/or 10-K, for a more
complete discussion of the risks and other factors that could
affect Pennant’s business, prospects and any forward-looking
statements. Except as required by the federal securities laws,
Pennant does not undertake any obligation to publicly update or
revise any forward-looking statements, whether as a result of new
information, future events, changing circumstances or any other
reason after the date of this press release.
Contact Information
Investor RelationsThe Pennant Group, Inc.(208)
506-6100ir@pennantgroup.com
SOURCE: The Pennant Group, Inc.
|
THE PENNANT GROUP, INC.CONDENSED
CONSOLIDATED STATEMENTS OF INCOME(unaudited, in
thousands, except for per-share amounts) |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Revenue |
$ |
180,688 |
|
|
$ |
140,192 |
|
|
$ |
506,348 |
|
|
$ |
398,937 |
|
|
|
|
|
|
|
|
|
Expense |
|
|
|
|
|
|
|
Cost of services |
|
144,468 |
|
|
|
112,384 |
|
|
|
405,776 |
|
|
|
321,162 |
|
Rent—cost of services |
|
10,906 |
|
|
|
10,006 |
|
|
|
31,814 |
|
|
|
29,439 |
|
General and administrative expense |
|
13,023 |
|
|
|
9,417 |
|
|
|
36,337 |
|
|
|
26,913 |
|
Depreciation and amortization |
|
1,493 |
|
|
|
1,323 |
|
|
|
4,292 |
|
|
|
3,817 |
|
Loss (gain) on disposition of property and equipment, net |
|
4 |
|
|
|
1 |
|
|
|
(751 |
) |
|
|
4 |
|
Total expenses |
|
169,894 |
|
|
|
133,131 |
|
|
|
477,468 |
|
|
|
381,335 |
|
Income from operations |
|
10,794 |
|
|
|
7,061 |
|
|
|
28,880 |
|
|
|
17,602 |
|
Other (expense) income, net: |
|
|
|
|
|
|
|
Other income (expense) |
|
109 |
|
|
|
(37 |
) |
|
|
192 |
|
|
|
28 |
|
Interest expense, net |
|
(2,892 |
) |
|
|
(1,496 |
) |
|
|
(6,306 |
) |
|
|
(4,355 |
) |
Other expense, net |
|
(2,783 |
) |
|
|
(1,533 |
) |
|
|
(6,114 |
) |
|
|
(4,327 |
) |
Income before provision for income taxes |
|
8,011 |
|
|
|
5,528 |
|
|
|
22,766 |
|
|
|
13,275 |
|
Provision for income taxes |
|
1,354 |
|
|
|
1,066 |
|
|
|
4,957 |
|
|
|
3,894 |
|
Net income |
|
6,657 |
|
|
|
4,462 |
|
|
|
17,809 |
|
|
|
9,381 |
|
Less: Net income attributable to noncontrolling interest |
|
452 |
|
|
|
79 |
|
|
|
1,008 |
|
|
|
351 |
|
Net income attributable to The Pennant Group, Inc. |
$ |
6,205 |
|
|
$ |
4,383 |
|
|
$ |
16,801 |
|
|
$ |
9,030 |
|
Earnings per share: |
|
|
|
|
|
|
|
Basic |
$ |
0.20 |
|
|
$ |
0.15 |
|
|
$ |
0.56 |
|
|
$ |
0.30 |
|
Diluted |
$ |
0.20 |
|
|
$ |
0.15 |
|
|
$ |
0.54 |
|
|
$ |
0.30 |
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
Basic |
|
30,281 |
|
|
|
29,912 |
|
|
|
30,157 |
|
|
|
29,825 |
|
Diluted |
|
31,363 |
|
|
|
30,206 |
|
|
|
30,869 |
|
|
|
30,178 |
|
|
THE PENNANT GROUP, INC.CONDENSED
CONSOLIDATED BALANCE SHEETS(in thousands, except
par value) |
|
|
September 30, 2024 |
|
December 31, 2023 |
Assets |
|
|
|
Current assets: |
|
|
|
Cash |
$ |
4,464 |
|
|
$ |
6,059 |
|
Accounts receivable—less allowance for doubtful accounts of $313
and $259, respectively |
|
84,025 |
|
|
|
61,116 |
|
Prepaid expenses and other current assets |
|
13,307 |
|
|
|
12,902 |
|
Total current assets |
|
101,796 |
|
|
|
80,077 |
|
Property and equipment, net |
|
41,865 |
|
|
|
28,598 |
|
Right-of-use assets |
|
265,441 |
|
|
|
262,923 |
|
Deferred tax assets, net |
|
245 |
|
|
|
— |
|
Restricted and other assets |
|
12,173 |
|
|
|
9,337 |
|
Goodwill |
|
129,337 |
|
|
|
91,014 |
|
Other indefinite-lived intangibles |
|
95,902 |
|
|
|
67,742 |
|
Total assets |
$ |
646,759 |
|
|
$ |
539,691 |
|
Liabilities and equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable |
$ |
15,888 |
|
|
$ |
10,841 |
|
Accrued wages and related liabilities |
|
36,565 |
|
|
|
28,256 |
|
Operating lease liabilities—current |
|
19,113 |
|
|
|
17,122 |
|
Other accrued liabilities |
|
19,029 |
|
|
|
15,330 |
|
Total current liabilities |
|
90,595 |
|
|
|
71,549 |
|
Long-term operating lease liabilities—less current portion |
|
248,907 |
|
|
|
248,596 |
|
Deferred tax liabilities, net |
|
818 |
|
|
|
1,855 |
|
Other long-term liabilities |
|
10,277 |
|
|
|
8,262 |
|
Long-term debt, net |
|
108,875 |
|
|
|
63,914 |
|
Total liabilities |
|
459,472 |
|
|
|
394,176 |
|
Commitments and contingencies |
|
|
|
Equity: |
|
|
|
Common stock, $0.001 par value; 100,000 shares authorized; 30,565
and 30,308 shares issued and outstanding, respectively, at
September 30, 2024; and 30,297 and 29,948 shares issued and
outstanding, respectively, at December 31, 2023 |
|
31 |
|
|
|
29 |
|
Additional paid-in capital |
|
117,947 |
|
|
|
105,712 |
|
Retained earnings |
|
51,464 |
|
|
|
34,663 |
|
Treasury stock, at cost, 3 shares at September 30, 2024 and
December 31, 2023 |
|
(65 |
) |
|
|
(65 |
) |
Total The Pennant Group, Inc. stockholders’ equity |
|
169,377 |
|
|
|
140,339 |
|
Noncontrolling interest |
|
17,910 |
|
|
|
5,176 |
|
Total equity |
|
187,287 |
|
|
|
145,515 |
|
Total liabilities and equity |
$ |
646,759 |
|
|
$ |
539,691 |
|
|
THE PENNANT GROUP, INC.CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS(in
thousands) |
|
The following table presents selected data from our condensed
consolidated statements of cash flows for the periods
presented: |
|
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
Net cash provided by operating activities |
$ |
18,729 |
|
|
$ |
27,910 |
|
Net cash used in investing activities |
|
(66,287 |
) |
|
|
(17,576 |
) |
Net cash provided by (used in) financing activities |
|
45,963 |
|
|
|
(9,030 |
) |
Net (decrease) increase in cash |
|
(1,595 |
) |
|
|
1,304 |
|
Cash beginning of period |
|
6,059 |
|
|
|
2,079 |
|
Cash end of period |
$ |
4,464 |
|
|
$ |
3,383 |
|
|
THE PENNANT GROUP, INC.REVENUE BY
SEGMENT(unaudited, dollars in
thousands) |
|
The following table sets forth our total revenue by segment and as
a percentage of total revenue for the periods indicated: |
|
|
Three Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
Revenue Dollars |
|
Revenue Percentage |
|
Revenue Dollars |
|
Revenue Percentage |
|
|
|
|
|
|
|
|
Home health and hospice services |
|
|
|
|
|
|
|
Home health |
$ |
60,988 |
|
|
33.8 |
% |
|
$ |
44,921 |
|
|
32.0 |
% |
Hospice |
|
62,757 |
|
|
34.7 |
|
|
|
50,371 |
|
|
35.9 |
|
Home care and other(a) |
|
11,927 |
|
|
6.6 |
|
|
|
6,182 |
|
|
4.4 |
|
Total home health and hospice services |
|
135,672 |
|
|
75.1 |
|
|
|
101,474 |
|
|
72.3 |
|
Senior living services |
|
45,016 |
|
|
24.9 |
|
|
|
38,718 |
|
|
27.7 |
|
Total revenue |
$ |
180,688 |
|
|
100.0 |
% |
|
$ |
140,192 |
|
|
100.0 |
% |
(a |
) |
Home care and other revenue is included with home health revenue in
other disclosures in this press release. |
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
|
Revenue Dollars |
|
Revenue Percentage |
|
Revenue Dollars |
|
Revenue Percentage |
|
|
|
|
|
|
|
|
Home health and hospice services |
|
|
|
|
|
|
|
Home health |
$ |
172,773 |
|
|
34.1 |
% |
|
$ |
129,112 |
|
|
32.4 |
% |
Hospice |
|
176,711 |
|
|
34.9 |
|
|
|
140,222 |
|
|
35.1 |
|
Home care and other(a) |
|
27,979 |
|
|
5.5 |
|
|
|
18,239 |
|
|
4.6 |
|
Total home health and hospice services |
|
377,463 |
|
|
74.5 |
|
|
|
287,573 |
|
|
72.1 |
|
Senior living services |
|
128,885 |
|
|
25.5 |
|
|
|
111,364 |
|
|
27.9 |
|
Total revenue |
$ |
506,348 |
|
|
100.0 |
% |
|
$ |
398,937 |
|
|
100.0 |
% |
(a |
) |
Home care and other revenue is included with home health revenue in
other disclosures in this press release. |
|
THE PENNANT GROUP, INC.SELECT PERFORMANCE
INDICATORS(unaudited, total revenue dollars in
thousands) |
|
The following table summarizes our overall home health and hospice
performance indicators for the each of the dates or periods
indicated: |
|
|
Three Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
Change |
|
% Change |
Total agency results: |
|
|
|
|
|
|
|
Home health and hospice revenue |
$ |
135,672 |
|
|
$ |
101,474 |
|
|
|
34,198 |
|
|
33.7 |
% |
|
|
|
|
|
|
|
|
Home health services: |
|
|
|
|
|
|
|
Total home health admissions |
|
14,993 |
|
|
|
10,829 |
|
|
|
4,164 |
|
|
38.5 |
% |
Total Medicare home health admissions |
|
6,071 |
|
|
|
4,640 |
|
|
|
1,431 |
|
|
30.8 |
% |
Average Medicare revenue per 60-day completed episode(a) |
$ |
3,760 |
|
|
$ |
3,480 |
|
|
$ |
280 |
|
|
8.0 |
% |
Hospice services: |
|
|
|
|
|
|
|
Total hospice admissions |
|
2,987 |
|
|
|
2,433 |
|
|
|
554 |
|
|
22.8 |
% |
Average daily census |
|
3,444 |
|
|
|
2,698 |
|
|
|
746 |
|
|
27.7 |
% |
Hospice Medicare revenue per day |
$ |
183 |
|
|
$ |
183 |
|
|
$ |
— |
|
|
— |
% |
|
Three Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
Change |
|
% Change |
Same agency(b)
results: |
|
|
|
|
|
|
|
Home health and hospice revenue |
$ |
110,748 |
|
|
$ |
98,732 |
|
|
$ |
12,016 |
|
|
12.2 |
% |
|
|
|
|
|
|
|
|
Home health services: |
|
|
|
|
|
|
|
Total home health admissions |
|
12,221 |
|
|
|
10,570 |
|
|
|
1,651 |
|
|
15.6 |
% |
Total Medicare home health admissions |
|
5,008 |
|
|
|
4,521 |
|
|
|
487 |
|
|
10.8 |
% |
Average Medicare revenue per 60-day completed episode(a) |
$ |
3,587 |
|
|
$ |
3,488 |
|
|
$ |
99 |
|
|
2.8 |
% |
Hospice services: |
|
|
|
|
|
|
|
Total hospice admissions |
|
2,624 |
|
|
|
2,351 |
|
|
|
273 |
|
|
11.6 |
% |
Average daily census |
|
2,995 |
|
|
|
2,650 |
|
|
|
345 |
|
|
13.0 |
% |
Hospice Medicare revenue per day |
$ |
184 |
|
|
$ |
186 |
|
|
$ |
(2 |
) |
|
(1.1 |
)% |
|
Nine Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
Change |
|
% Change |
Total agency results: |
|
|
|
|
|
|
|
Home health and hospice revenue |
$ |
377,463 |
|
|
$ |
287,573 |
|
|
$ |
89,890 |
|
|
31.3 |
% |
|
|
|
|
|
|
|
|
Home health services: |
|
|
|
|
|
|
|
Total home health admissions |
|
43,782 |
|
|
|
32,180 |
|
|
|
11,602 |
|
|
36.1 |
% |
Total Medicare home health admissions |
|
18,155 |
|
|
|
14,437 |
|
|
|
3,718 |
|
|
25.8 |
% |
Average Medicare revenue per 60-day completed episode(a) |
$ |
3,646 |
|
|
$ |
3,467 |
|
|
$ |
179 |
|
|
5.2 |
% |
Hospice services: |
|
|
|
|
|
|
|
Total hospice admissions |
|
9,118 |
|
|
|
7,206 |
|
|
|
1,912 |
|
|
26.5 |
% |
Average daily census |
|
3,209 |
|
|
|
2,544 |
|
|
|
665 |
|
|
26.1 |
% |
Hospice Medicare revenue per day |
$ |
182 |
|
|
$ |
184 |
|
|
$ |
(2 |
) |
|
(1.1 |
)% |
|
Nine Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
Change |
|
% Change |
Same agency(b)
results: |
|
|
|
|
|
|
|
Home health and hospice revenue |
$ |
322,941 |
|
|
$ |
284,228 |
|
|
$ |
38,713 |
|
|
13.6 |
% |
|
|
|
|
|
|
|
|
Home health services: |
|
|
|
|
|
|
|
Total home health admissions |
|
36,623 |
|
|
|
31,710 |
|
|
|
4,913 |
|
|
15.5 |
% |
Total Medicare home health admissions |
|
15,441 |
|
|
|
14,221 |
|
|
|
1,220 |
|
|
8.6 |
% |
Average Medicare revenue per 60-day completed episode(a) |
$ |
3,546 |
|
|
$ |
3,469 |
|
|
$ |
77 |
|
|
2.2 |
% |
Hospice services: |
|
|
|
|
|
|
|
Total hospice admissions |
|
7,970 |
|
|
|
7,104 |
|
|
|
866 |
|
|
12.2 |
% |
Average daily census |
|
2,851 |
|
|
|
2,528 |
|
|
|
323 |
|
|
12.8 |
% |
Hospice Medicare revenue per day |
$ |
185 |
|
|
$ |
186 |
|
|
$ |
(1 |
) |
|
(0.5 |
)% |
(a |
) |
The year to date average for Medicare revenue per 60-day completed
episode includes post period claim adjustments for prior
periods. |
(b |
) |
Same agency results represent all agencies purchased or licensed
prior to January 1, 2023. |
|
The following
table summarizes our senior living performance indicators for the
periods indicated: |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Total senior living results: |
|
|
|
|
|
|
|
Senior living revenue |
$ |
45,016 |
|
|
$ |
38,718 |
|
|
$ |
128,885 |
|
|
$ |
111,364 |
|
|
|
|
|
|
|
|
|
Occupancy |
|
79.1 |
% |
|
|
78.9 |
% |
|
|
78.9 |
% |
|
|
78.4 |
% |
Average monthly revenue per occupied unit |
$ |
4,836 |
|
|
$ |
4,486 |
|
|
$ |
4,758 |
|
|
$ |
4,401 |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Same store senior living(a)
results: |
|
|
|
|
|
|
|
Senior living revenue |
$ |
41,030 |
|
|
$ |
38,126 |
|
|
$ |
119,625 |
|
|
$ |
110,225 |
|
|
|
|
|
|
|
|
|
Occupancy |
|
80.2 |
% |
|
|
80.1 |
% |
|
|
79.7 |
% |
|
|
79.6 |
% |
Average monthly revenue per occupied unit |
$ |
4,790 |
|
|
$ |
4,454 |
|
|
$ |
4,724 |
|
|
$ |
4,380 |
|
(a) |
|
Same store senior living results is defined as all senior living
communities excluding affiliate memory care units in transition,
and new senior living operations acquired in 2023 or 2024. |
|
THE PENNANT GROUP, INC.REVENUE BY PAYOR
SOURCE(unaudited, dollars in
thousands) |
|
The following table presents our total revenue by payor source as a
percentage of total revenue for the periods indicated: |
|
|
|
Three Months Ended September 30, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
Revenue Dollars |
|
Revenue Percentage |
|
Revenue Dollars |
|
Revenue Percentage |
|
|
|
|
|
|
|
|
|
Revenue: |
|
|
|
|
|
|
|
|
Medicare |
|
$ |
86,919 |
|
|
48.1 |
% |
|
$ |
67,925 |
|
|
48.5 |
% |
Medicaid |
|
|
22,715 |
|
|
12.6 |
|
|
|
19,893 |
|
|
14.2 |
|
Subtotal |
|
|
109,634 |
|
|
60.7 |
|
|
|
87,818 |
|
|
62.7 |
|
Managed Care |
|
|
24,652 |
|
|
13.6 |
|
|
|
19,158 |
|
|
13.6 |
|
Private and Other(a) |
|
|
46,402 |
|
|
25.7 |
|
|
|
33,216 |
|
|
23.7 |
|
Total revenue |
|
$ |
180,688 |
|
|
100.0 |
% |
|
$ |
140,192 |
|
|
100.0 |
% |
(a) |
|
Private and other payors includes revenue from all payors generated
in the Company’s home care operations and management services
agreement. |
|
|
Nine Months Ended September 30, |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
Revenue Dollars |
|
Revenue Percentage |
|
Revenue Dollars |
|
Revenue Percentage |
|
|
|
|
|
|
|
|
|
Revenue: |
|
|
|
|
|
|
|
|
Medicare |
|
$ |
245,746 |
|
|
48.5 |
% |
|
$ |
192,895 |
|
|
48.3 |
% |
Medicaid |
|
|
66,386 |
|
|
13.1 |
|
|
|
56,455 |
|
|
14.2 |
|
Subtotal |
|
|
312,132 |
|
|
61.6 |
|
|
|
249,350 |
|
|
62.5 |
|
Managed Care |
|
|
66,084 |
|
|
13.1 |
|
|
|
53,538 |
|
|
13.4 |
|
Private and Other(a) |
|
|
128,132 |
|
|
25.3 |
|
|
|
96,049 |
|
|
24.1 |
|
Total revenue |
|
$ |
506,348 |
|
|
100.0 |
% |
|
$ |
398,937 |
|
|
100.0 |
% |
(a) |
|
Private and other payors includes revenue from all payors generated
in the Company’s home care operations and management services
agreement. |
|
THE PENNANT GROUP, INC.RECONCILIATION OF
GAAP TO NON-GAAP FINANCIAL INFORMATION(unaudited,
in thousands, except per share data) |
|
The following
table reconciles net income to Non-GAAP net income for the periods
presented: |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Net income attributable to The Pennant Group, Inc. |
$ |
6,205 |
|
|
$ |
4,383 |
|
|
$ |
16,801 |
|
|
$ |
9,030 |
|
|
|
|
|
|
|
|
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
Costs at start-up operations(a) |
|
66 |
|
|
|
59 |
|
|
|
244 |
|
|
|
1,060 |
|
Share-based compensation expense(b) |
|
2,342 |
|
|
|
1,391 |
|
|
|
5,817 |
|
|
|
4,164 |
|
Acquisition related costs and credit allowances(c) |
|
494 |
|
|
|
71 |
|
|
|
996 |
|
|
|
175 |
|
Interest expense - write off deferred financing fees(e) |
|
428 |
|
|
|
— |
|
|
|
428 |
|
|
|
— |
|
Costs associated with transitioning operations(d) |
|
68 |
|
|
|
90 |
|
|
|
(418 |
) |
|
|
759 |
|
Unusual, non-recurring or redundant charges(e) |
|
239 |
|
|
|
1,009 |
|
|
|
546 |
|
|
|
1,633 |
|
Provision for income taxes on Non-GAAP adjustments(f) |
|
(1,675 |
) |
|
|
(1,031 |
) |
|
|
(2,942 |
) |
|
|
(1,562 |
) |
Non-GAAP net income |
$ |
8,167 |
|
|
$ |
5,972 |
|
|
$ |
21,472 |
|
|
$ |
15,259 |
|
|
|
|
|
|
|
|
|
Dilutive Earnings Per Share As Reported |
|
|
|
|
|
|
|
Net Income |
$ |
0.20 |
|
|
$ |
0.15 |
|
|
$ |
0.54 |
|
|
$ |
0.30 |
|
Average number of shares outstanding |
|
31,363 |
|
|
|
30,206 |
|
|
|
30,869 |
|
|
|
30,178 |
|
|
|
|
|
|
|
|
|
Adjusted Diluted Earnings Per Share |
|
|
|
|
|
|
|
Net Income |
$ |
0.26 |
|
|
$ |
0.20 |
|
|
$ |
0.70 |
|
|
$ |
0.51 |
|
Average number of shares outstanding |
|
31,363 |
|
|
|
30,206 |
|
|
|
30,869 |
|
|
|
30,178 |
|
(a) |
|
Represents results related to start-up operations. |
|
|
|
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
Revenue |
$ |
— |
|
|
$ |
(2,928 |
) |
|
$ |
(4,956 |
) |
|
$ |
(8,821 |
) |
|
|
Cost of services |
|
65 |
|
|
|
2,820 |
|
|
|
4,884 |
|
|
|
8,981 |
|
|
|
Rent |
|
— |
|
|
|
162 |
|
|
|
306 |
|
|
|
885 |
|
|
|
Depreciation & amortization |
|
1 |
|
|
|
5 |
|
|
|
10 |
|
|
|
15 |
|
|
|
Total Non-GAAP adjustment |
$ |
66 |
|
|
$ |
59 |
|
|
$ |
244 |
|
|
$ |
1,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) |
|
Represents share-based compensation expense incurred for the
periods presented. |
|
|
|
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
Cost of services |
$ |
1,069 |
|
|
$ |
819 |
|
|
$ |
2,814 |
|
|
$ |
2,288 |
|
|
|
General and administrative |
|
1,273 |
|
|
|
572 |
|
|
|
3,003 |
|
|
|
1,876 |
|
|
|
Total Non-GAAP adjustment |
$ |
2,342 |
|
|
$ |
1,391 |
|
|
$ |
5,817 |
|
|
$ |
4,164 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) |
|
Represents costs incurred to acquire an operation that are not
capitalizable. |
(d) |
|
During the nine months ended September 30, 2023, an affiliate of
the Company placed its memory care units into transition and began
seeking to sublease the units to an unrelated third party. The
amount above represents the net operating impact attributable to
the units in transition. The amounts reported exclude rent and
depreciation and amortization expense related to such operations
and include legal settlement costs associated with an entity
transitioned to Ensign. |
|
|
|
|
|
|
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
|
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
Revenue |
$ |
— |
|
|
$ |
(4 |
) |
|
$ |
(1 |
) |
|
$ |
(4 |
) |
|
|
Cost of services |
|
12 |
|
|
|
14 |
|
|
|
(582 |
) |
|
|
599 |
|
|
|
Rent |
|
53 |
|
|
|
77 |
|
|
|
157 |
|
|
|
156 |
|
|
|
Depreciation |
|
3 |
|
|
|
3 |
|
|
|
8 |
|
|
|
8 |
|
|
|
Total Non-GAAP adjustment |
$ |
68 |
|
|
$ |
90 |
|
|
$ |
(418 |
) |
|
$ |
759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(e) |
|
Represents unusual or non-recurring charges for legal services,
implementation costs, integration costs, and consulting fees in
general and administrative and cost of services expenses. |
|
|
|
|
|
|
|
|
|
|
|
|
(f) |
|
Represents an adjustment to the provision for income tax to the
year-to-date effective tax rate of 26.0% and 25.9% for the nine
months ended September 30, 2024 and 2023, respectively. This rate
excludes the tax benefit of share-based payment awards. |
The table below
reconciles Consolidated net income to the Consolidated Non-GAAP
financial measures, Consolidated Adjusted EBITDA, and to the
Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the
periods presented: |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Consolidated net income |
$ |
6,657 |
|
|
$ |
4,462 |
|
|
$ |
17,809 |
|
|
$ |
9,381 |
|
Less: Net income attributable to noncontrolling interest |
|
452 |
|
|
|
79 |
|
|
|
1,008 |
|
|
|
351 |
|
Add: Provision for income taxes |
|
1,354 |
|
|
|
1,066 |
|
|
|
4,957 |
|
|
|
3,894 |
|
Net interest expense |
|
2,892 |
|
|
|
1,496 |
|
|
|
6,306 |
|
|
|
4,355 |
|
Depreciation and amortization |
|
1,493 |
|
|
|
1,323 |
|
|
|
4,292 |
|
|
|
3,817 |
|
Consolidated EBITDA |
|
11,944 |
|
|
|
8,268 |
|
|
|
32,356 |
|
|
|
21,096 |
|
Adjustments to Consolidated EBITDA |
|
|
|
|
|
|
|
Add: Costs at start-up operations(a) |
|
65 |
|
|
|
(108 |
) |
|
|
(72 |
) |
|
|
160 |
|
Share-based compensation expense(b) |
|
2,342 |
|
|
|
1,391 |
|
|
|
5,817 |
|
|
|
4,164 |
|
Acquisition related costs and credit allowances(c) |
|
494 |
|
|
|
71 |
|
|
|
996 |
|
|
|
175 |
|
Costs associated with transitioning operations(d) |
|
12 |
|
|
|
10 |
|
|
|
(583 |
) |
|
|
595 |
|
Unusual, non-recurring or redundant charges(e) |
|
239 |
|
|
|
1,009 |
|
|
|
546 |
|
|
|
1,633 |
|
Rent related to items (a) and (d) above |
|
53 |
|
|
|
239 |
|
|
|
463 |
|
|
|
1,041 |
|
Consolidated Adjusted EBITDA |
|
15,149 |
|
|
|
10,880 |
|
|
|
39,523 |
|
|
|
28,864 |
|
Rent—cost of services |
|
10,906 |
|
|
|
10,006 |
|
|
|
31,814 |
|
|
|
29,439 |
|
Rent related to items (a) and (d) above |
|
(53 |
) |
|
|
(239 |
) |
|
|
(463 |
) |
|
|
(1,041 |
) |
Adjusted rent—cost of services |
|
10,853 |
|
|
|
9,767 |
|
|
|
31,351 |
|
|
|
28,398 |
|
Consolidated Adjusted EBITDAR(f) |
$ |
26,002 |
|
|
|
|
$ |
70,874 |
|
|
|
(a) |
|
Represents results related to start-up operations. This amount
excludes rent and depreciation and amortization expense related to
such operations. |
(b) |
|
Share-based compensation expense and related payroll taxes
incurred. Share-based compensation expense and related payroll
taxes are included in cost of services and general and
administrative expense. |
(c) |
|
Non-capitalizable costs associated with acquisitions, credit
allowances, and write offs for amounts in dispute with the prior
owners of certain acquired operations. |
(d) |
|
During the nine months ended September 30, 2023, an affiliate of
the Company placed its memory care units into transition and began
seeking to sublease the units to an unrelated third party. The
amount above represents the net operating impact attributable to
the units in transition. The amounts reported exclude rent and
depreciation and amortization expense related to such operations
and include legal settlement costs associated with an entity
transitioned to Ensign. |
(e) |
|
Represents unusual or non-recurring charges for legal services,
implementation costs, integration costs, and consulting fees in
general and administrative and cost of services expenses. |
(f) |
|
This measure is a valuation measure and is displayed thusly, it is
not a performance measure as it excludes rent expense, which is a
normal and recurring operating expense and, as such, does not
reflect our cash requirements for leasing commitments. Our
presentation of Consolidated Adjusted EBITDAR should not be
construed as a financial performance measure. |
The following
table present certain financial information regarding our
reportable segments. General and administrative expenses are not
allocated to the reportable segments and are included in “All
Other”: |
|
|
Home Healthand HospiceServices |
|
Senior LivingServices |
|
All Other |
|
Total |
Segment GAAP Financial Measures: |
|
|
|
|
|
|
|
Three Months Ended September 30, 2024 |
|
|
|
|
|
|
|
Revenue |
$ |
135,672 |
|
|
$ |
45,016 |
|
|
$ |
— |
|
|
$ |
180,688 |
|
Segment Adjusted EBITDAR from Operations |
$ |
23,724 |
|
|
$ |
13,411 |
|
|
$ |
(11,133 |
) |
|
$ |
26,002 |
|
Three Months Ended September 30, 2023 |
|
|
|
|
|
|
|
Revenue |
$ |
101,474 |
|
|
$ |
38,718 |
|
|
$ |
— |
|
|
$ |
140,192 |
|
Segment Adjusted EBITDAR from Operations |
$ |
17,271 |
|
|
$ |
11,473 |
|
|
$ |
(8,097 |
) |
|
$ |
20,647 |
|
|
Home Healthand HospiceServices |
|
Senior LivingServices |
|
All Other |
|
Total |
Segment GAAP Financial Measures: |
|
|
|
|
|
|
|
Nine Months Ended September 30, 2024 |
|
|
|
|
|
|
|
Revenue |
$ |
377,463 |
|
|
$ |
128,885 |
|
|
$ |
— |
|
|
$ |
506,348 |
|
Segment Adjusted EBITDAR from Operations |
$ |
64,488 |
|
|
$ |
38,226 |
|
|
$ |
(31,840 |
) |
|
$ |
70,874 |
|
Nine Months Ended September 30, 2023 |
|
|
|
|
|
|
|
Revenue |
$ |
287,573 |
|
|
$ |
111,364 |
|
|
$ |
— |
|
|
$ |
398,937 |
|
Segment Adjusted EBITDAR from Operations |
$ |
47,364 |
|
|
$ |
33,394 |
|
|
$ |
(23,496 |
) |
|
$ |
57,262 |
|
The table below
provides a reconciliation of Segment Adjusted EBITDAR from
Operations above to Condensed Consolidated Income from
Operations: |
|
|
Three Months EndedSeptember 30, |
|
Nine Months EndedSeptember 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Segment Adjusted EBITDAR from Operations(a) |
$ |
26,002 |
|
|
$ |
20,647 |
|
|
$ |
70,874 |
|
|
$ |
57,262 |
|
Less: Depreciation and amortization |
|
1,493 |
|
|
|
1,323 |
|
|
|
4,292 |
|
|
|
3,817 |
|
Rent—cost of services |
|
10,906 |
|
|
|
10,006 |
|
|
|
31,814 |
|
|
|
29,439 |
|
Other income |
|
109 |
|
|
|
(37 |
) |
|
|
192 |
|
|
|
28 |
|
Adjustments to Segment EBITDAR from Operations: |
|
|
|
|
|
|
|
Less: Costs at start-up operations(b) |
|
65 |
|
|
|
(108 |
) |
|
|
(72 |
) |
|
|
160 |
|
Share-based compensation expense(c) |
|
2,342 |
|
|
|
1,391 |
|
|
|
5,817 |
|
|
|
4,164 |
|
Acquisition related costs and credit allowances(d) |
|
494 |
|
|
|
71 |
|
|
|
996 |
|
|
|
175 |
|
Costs associated with transitioning operations(e) |
|
12 |
|
|
|
10 |
|
|
|
(583 |
) |
|
|
595 |
|
Unusual, non-recurring or redundant charges(f) |
|
239 |
|
|
|
1,009 |
|
|
|
546 |
|
|
|
1,633 |
|
Add: Net income attributable to noncontrolling interest |
|
452 |
|
|
|
79 |
|
|
|
1,008 |
|
|
|
351 |
|
Consolidated Income from Operations |
$ |
10,794 |
|
|
$ |
7,061 |
|
|
$ |
28,880 |
|
|
$ |
17,602 |
|
(a) |
|
Segment Adjusted EBITDAR from Operations is net income (loss)
attributable to the Company's reportable segments excluding
interest expense, provision for income taxes, depreciation and
amortization expense, rent, and, in order to view the operations
performance on a comparable basis from period to period, certain
adjustments including: (1) costs at start-up operations, (2)
share-based compensation, (3) acquisition related costs and credit
allowances, (4) the costs associated with transitioning operations,
(5) unusual, non-recurring or redundant charges, and (6) net income
attributable to noncontrolling interest. General and administrative
expenses are not allocated to the reportable segments, and are
included as “All Other,” accordingly the segment earnings measure
reported is before allocation of corporate general and
administrative expenses. The Company's segment measures may be
different from the calculation methods used by other companies and,
therefore, comparability may be limited. |
(b) |
|
Represents results related to start-up operations. This amount
excludes rent and depreciation and amortization expense related to
such operations. |
(c) |
|
Share-based compensation expense and related payroll taxes
incurred. Share-based compensation expense and related payroll
taxes are included in cost of services and general and
administrative expense. |
(d) |
|
Non-capitalizable costs associated with acquisitions, credit
allowances, and write offs for amounts in dispute with the prior
owners of certain acquired operations. |
(e) |
|
During the nine months ended September 30, 2023, an affiliate of
the Company placed its memory care units into transition and began
seeking to sublease the units to an unrelated third party. The
amount above represents the net operating impact attributable to
the units in transition. The amounts reported exclude rent and
depreciation and amortization expense related to such operations
and include legal settlement costs associated with an entity
transitioned to Ensign. |
(f) |
|
Represents unusual or non-recurring charges for legal services,
implementation costs, integration costs, and consulting fees in
general and administrative and cost of services expenses. |
The tables below
reconcile Segment Adjusted EBITDAR from Operations to Segment
Adjusted EBITDA from Operations for each reportable segment for the
periods presented: |
|
|
Three Months Ended September 30, |
|
Home Health andHospice |
|
Senior Living |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Segment Adjusted EBITDAR from Operations |
$ |
23,724 |
|
|
$ |
17,271 |
|
|
$ |
13,411 |
|
|
$ |
11,473 |
|
Less: Rent—cost of services |
|
1,861 |
|
|
|
1,439 |
|
|
|
9,045 |
|
|
|
8,567 |
|
Rent related to start-up and transitioning operations |
|
— |
|
|
|
(72 |
) |
|
|
(53 |
) |
|
|
(167 |
) |
Segment Adjusted EBITDA from Operations |
$ |
21,863 |
|
|
$ |
15,904 |
|
|
$ |
4,419 |
|
|
$ |
3,073 |
|
|
Nine Months Ended September 30, |
|
Home Health andHospice |
|
Senior Living |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Segment Adjusted EBITDAR from Operations |
$ |
64,488 |
|
|
$ |
47,364 |
|
|
$ |
38,226 |
|
|
$ |
33,394 |
|
Less: Rent—cost of services |
|
5,254 |
|
|
|
4,136 |
|
|
|
26,560 |
|
|
|
25,303 |
|
Rent related to start-up and transitioning operations |
|
(122 |
) |
|
|
(248 |
) |
|
|
(341 |
) |
|
|
(793 |
) |
Segment Adjusted EBITDA from Operations |
$ |
59,356 |
|
|
$ |
43,476 |
|
|
$ |
12,007 |
|
|
$ |
8,884 |
|
Discussion of Non-GAAP Financial
Measures
EBITDA consists of net income before (a)
interest expense, net, (b) (benefits) provisions for income taxes,
and (c) depreciation and amortization. Adjusted EBITDA consists of
net income attributable to the Company before (a) interest expense,
net (b) (benefits) provisions for income taxes, (c) depreciation
and amortization, (d) costs incurred for start-up operations,
including rent and excluding depreciation, interest and income
taxes, (e) share-based compensation expense, (f) non-capitalizable
acquisition related costs and credit allowances, (g) net costs
associated with transitioning operations, (h) unusual,
non-recurring or redundant charges and (i) net income attributable
to noncontrolling interest. Consolidated Adjusted EBITDAR is a
valuation measure applicable to current periods only and consists
of net income attributable to the Company before (a) interest
expense, net, (b) (benefits) provisions for income taxes, (c)
depreciation and amortization, (d) rent-cost of services, (e) costs
incurred for start-up operations, excluding rent, depreciation,
interest and income taxes, (f) share-based compensation expense,
(g) acquisition related costs and credit allowances, (h) redundant
or non-recurring transition services costs, (i) costs associated
with transitioning operations, (j) unusual, non-recurring or
redundant charges and (j) net income attributable to noncontrolling
interest. The company believes that the presentation of EBITDA,
adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income
and adjusted earnings per share provides important supplemental
information to management and investors to evaluate the company’s
operating performance. The company believes disclosure of adjusted
net income, adjusted net income per share, EBITDA, adjusted EBITDA
and consolidated adjusted EBITDAR has economic substance because
the excluded revenues and expenses are infrequent in nature and are
variable in nature, or do not represent current revenues or cash
expenditures. A material limitation associated with the use of
these measures as compared to the GAAP measures of net income and
diluted earnings per share is that they may not be comparable with
the calculation of net income and diluted earnings per share for
other companies in the company's industry. These non-GAAP financial
measures should not be relied upon to the exclusion of GAAP
financial measures. For further information regarding why the
company believes that this non-GAAP measure provides useful
information to investors, the specific manner in which management
uses this measure, and some of the limitations associated with the
use of this measure, please refer to the company's periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K and Quarterly Report on Form 10-Q. The
company’s periodic filings are available on the SEC's website at
www.sec.gov or under the "Financial Information" link of the
Investor Relations section on Pennant’s website at
http://www.pennantgroup.com.
Pennant (NASDAQ:PNTG)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Pennant (NASDAQ:PNTG)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024